Syringe and Needle Market Size to Reach Revenues of over $34 Billion by 2025 - Arizton
CHICAGO, Aug. 3, 2020 /PRNewswire/ -- The global syringe and needle market is expected to grow at a CAGR of over 10% during the period 2019?2025.
Key Highlights Offered in the Report:
Safety needles are the major leading segment and are growing at a faster growth rate, thereby boosting the market in the coming years.
A surge in the number of vaccinations, and rising hospital admission are the major driver of the global market during the forecast period.
Asia Pacific is anticipated to exhibit the highest CAGR of over 13% and the region has the highest absolute growth of over 111%, during the forecast period. This growth in the region is due to the rising patient population and increasing vaccination.
Also, the upsurge in the COVID-19 pandemic cases has increased the demand for needles and syringes, as there is increasing patient population that require IV, as well as vaccination to treat the rising COVID-19 patients, this is leading to positive growth in the global market.
Moreover, the rising various initiatives such as, needles syringes program has increased the safety among end-users, along with availability of vending machines that provides safe and hygiene syringes and needles is boosting the market growth.
Vendors need to strategically focus on the development and commercial launch of safe advanced syringes and needles that can be used in hospitals, clinics, and other healthcare facilities. Vendors in the syringes and needles market should penetrate and tap the huge growth potential in developed and emerging nations during the forecast period.
Key Offerings:
Market Size & Forecast by Revenue | 2019?2025
Market Dynamics ? Leading trends, growth drivers, restraints, and investment opportunities
Market Segmentation ? A detailed analysis by products, patient group, end-users, and geography
Competitive Landscape ? 7 key vendors and 34 other vendors
North America dominates the syringe market. APAC is expected to grow at a faster growth rate due to the presence of a large patient population that requires syringes for medication and blood testing. The increased adoption of injectable drugs, technological advancements, the increase in the geriatric population, and the growing number of vaccination and immunization programs for pediatrics, as well as adults, are expected to drive the volume growth over the next few years.
The pediatric segment is expected to grow at the fastest CAGR during the forecast period. The segment is driven by improving birth rates across the world, boosting the usage of injections. Moreover, the increase in chronic disease prevalence in the pediatric population is one of the significant factors that is driving the usage of syringes and needles.
The clinic end-user segment is expected to grow at a CAGR of over 9% during the period 2019¬2025. IVF and rehabilitation clinics use a high number of needles and syringes for medical and vaccination procedures, thereby boosting the market. Similarly, the home care setting segment is expected to experience growth as the elderly population prefers these settings over hospitals and other clinics.
Syringe and Needle Market by Products
Syringes
Types
General Syringes
Specialized Syringes
Usability
Disposable Syringes
Sterilizable Syringes
Needles
Types
Conventional Needles
Safety Needles
Syringe and Needle Market by Patient Group
Adults
Pediatric Patients
Syringe and Needle Market by End-users
Hospitals
Clinics
Home Healthcare Settings
Others
Syringe and Needle Market ? Dynamics
The demand for self-administered injectable devices among other drug delivery devices is growing at a significant rate in recent years. These pre-filled devices contain syringes or cartridges that enable patients to easily select their dosage and administer medication accurately with minimal preparation or clean up. Most self-administered injectable devices treat emergency conditions such as allergies or chronic conditions like diabetes and rheumatoid arthritis. Self-injection devices consist of accurate dosage volumes and reconstituted drugs, which help patients eliminate confusion regarding dosage and wastage of medication. These syringes are thus helpful in the self-administration of drugs.
Key Drivers and Trends fueling Market Growth:
Rapid Advancements in Needle & Syringe Design & Technology
High Growth Potential in Emerging Economies
Growing Demand for Safety Needles & Syringes
Global Expansion of Needle Syringe Programs
Syringe and Needle Market ? Geography
The market in North America is driven by the rising incidence of chronic and infectious diseases, where hospitals, clinics, and ASCs are the largest revenue generators. The US and Canada are the primary revenue contributors to the market in North America. The adoption of syringes & needles with safety mechanisms is higher in North America compared to other geographical regions.
Arizton Advisory and Intelligence is an innovation and quality-driven firm, which offers cutting-edge research solutions to clients across the world. We excel in providing comprehensive market intelligence reports and advisory and consulting services.
We offer comprehensive market research reports on industries such as consumer goods & retail technology, automotive and mobility, smart tech, healthcare, and life sciences, industrial machinery, chemicals and materials, IT and media, logistics and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.
Arizton comprises a team of exuberant and well-experienced analysts who have mastered in generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.
In response to the unprecedented challenges that Latin America has faced during various health crises such as AH1N1, Zika, COVID-19, and Dengue, a prominent group of former health ministers and public health academics from the region has published in...
Simply Better Brands Corp. ("SBBC" or the "Company") announces that, further to the Company's news release dated January 25, 2023, and in connection with the Branding Earnout Agreement dated January 25, 2023, the Company has issued 89,966 common...
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF has commenced an investigation into Chegg, Inc. .
Chegg is a publicly traded educational technology...
Today, the Biden-Harris Administration released a final rule under Section 1557, the core nondiscrimination provision of the Affordable Care Act. This groundbreaking rule marks a critical step in protecting access to health care and coverage for...
Farmmi, Inc. ("Farmmi" or the "Company") , an agriculture products supplier in China, today announced that on April 22, 2024, it received a letter from The Nasdaq Stock Market LLC ("Nasdaq"), notifying the Company that it is currently not in...
AMC Entertainment Holdings, Inc. (the "Company," or "AMC"), today released preliminary results for the first quarter ended March 31, 2024. The preliminary results are unaudited, subject to completion of the Company's financial reporting processes,...